CA1176158A - Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain - Google Patents

Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain

Info

Publication number
CA1176158A
CA1176158A CA000409900A CA409900A CA1176158A CA 1176158 A CA1176158 A CA 1176158A CA 000409900 A CA000409900 A CA 000409900A CA 409900 A CA409900 A CA 409900A CA 1176158 A CA1176158 A CA 1176158A
Authority
CA
Canada
Prior art keywords
human
insulin
peptide
composition
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000409900A
Other languages
English (en)
Inventor
Ronald E. Chance
Bruce H. Frank
John A. Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1176158A publication Critical patent/CA1176158A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000409900A 1981-08-27 1982-08-23 Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain Expired CA1176158A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27
US296,715 1981-08-27

Publications (1)

Publication Number Publication Date
CA1176158A true CA1176158A (fr) 1984-10-16

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000409900A Expired CA1176158A (fr) 1981-08-27 1982-08-23 Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain

Country Status (20)

Country Link
JP (1) JPS5846024A (fr)
AU (1) AU551879B2 (fr)
BE (1) BE894185A (fr)
CA (1) CA1176158A (fr)
CH (1) CH650679A5 (fr)
DE (1) DE3232034A1 (fr)
DZ (1) DZ452A1 (fr)
FR (1) FR2513126B1 (fr)
GB (1) GB2104382B (fr)
IE (1) IE54119B1 (fr)
IL (1) IL66611A0 (fr)
IT (1) IT1153182B (fr)
LU (1) LU84359A1 (fr)
MW (1) MW3882A1 (fr)
NL (1) NL192192C (fr)
NZ (1) NZ201682A (fr)
PH (1) PH19361A (fr)
SE (1) SE460334B (fr)
ZA (1) ZA826159B (fr)
ZW (1) ZW17482A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610649B2 (en) 1996-09-27 2003-08-26 Creative Peptides Sweden Ab Insulin C-peptides

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ　インダストリ　アクティーゼルスカブ ポリペプチド製剤
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
DE10075034I1 (de) * 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
ATE63821T1 (de) * 1987-08-14 1991-06-15 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033240A2 (fr) 2008-09-19 2010-03-25 Nektar Therapeutics Polymères à base de glucide pour administration de médicaments et leurs conjugués
JP2013533217A (ja) 2010-05-17 2013-08-22 セビックス・インコーポレイテッド Ｐｅｇ化ｃ−ペプチド
WO2013075117A2 (fr) 2011-11-17 2013-05-23 John Wahren Peptide c pegylé

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610649B2 (en) 1996-09-27 2003-08-26 Creative Peptides Sweden Ab Insulin C-peptides

Also Published As

Publication number Publication date
FR2513126A1 (fr) 1983-03-25
DE3232034A1 (de) 1983-03-10
IT1153182B (it) 1987-01-14
IE54119B1 (en) 1989-06-21
IT8223017A0 (it) 1982-08-27
NZ201682A (en) 1985-08-16
IL66611A0 (en) 1982-12-31
PH19361A (en) 1986-04-02
NL8203315A (nl) 1983-03-16
NL192192C (nl) 1997-03-04
SE8204873L (sv) 1983-02-28
DZ452A1 (fr) 2004-09-13
SE460334B (sv) 1989-10-02
CH650679A5 (de) 1985-08-15
NL192192B (nl) 1996-11-01
DE3232034C2 (fr) 1991-04-11
IE822064L (en) 1983-02-27
JPS5846024A (ja) 1983-03-17
ZW17482A1 (en) 1982-11-17
SE8204873D0 (sv) 1982-08-25
GB2104382A (en) 1983-03-09
GB2104382B (en) 1984-12-19
FR2513126B1 (fr) 1986-04-18
ZA826159B (en) 1984-04-25
MW3882A1 (en) 1984-07-11
BE894185A (fr) 1983-02-24
LU84359A1 (fr) 1983-02-28
AU8759482A (en) 1983-03-03
AU551879B2 (en) 1986-05-15

Similar Documents

Publication Publication Date Title
CA1176158A (fr) Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain
CA1176161A (fr) Composes pharmaceutiques contenant de l'insuline humaine et de la proinsuline
KR100546225B1 (ko) 신속한 작용개시를 나타내는 인슐린 유도체
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
RU2176646C2 (ru) Инсулин и его производные с повышенной способностью связывать цинк
ZA200600846B (en) Novel insulin derivatives
US4654324A (en) Human proinsulin pharmaceutical formulations
JP4402296B2 (ja) 亜鉛結合性が増大された新規なインスリン同族体
CA1176160A (fr) Compose pharmaceutique de pro-insuline humaine
CA1176159A (fr) Compose pharmaceutique contenant de l'insuline humaine, un c-peptide et de la pro-insuline
NZ546912A (en) Use of C-peptides in manufacture of a medicament in once daily dose for treating diabetes and microvascular complications
WO1997012631A1 (fr) Medicament pour ameliorer la fonction renale
WO1998041222A1 (fr) Formulations de proteine de l'obesite
JPH08188538A (ja) ニューロレプト麻酔時の血圧調節剤

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry